Clinical Trials Logo
  1. Home
  2. HIV-1 Infection
  3. NCT03579381

Specimen Repository for HIV Immunopathogenesis

HIV-1-infection Clinical Trial

Official title:
Specimen Repository for HIV Immunopathogenesis

Clinical Trial Summary

Specimen Repository for HIV Immunopathogenesis Studies

Clinical Trial Description

The goal is to build a large specimen repository for collaborating scientists to run studies of immunity and HIV-1. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03579381
Study type Observational
Source AIDS Healthcare Foundation
Contact Leonardo Colemon, MA
Phone 323-498-6680
Email leonardo.colemon@aidshealth.org
Status Recruiting
Phase
Start date July 31, 2017
Completion date December 10, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03227731 - Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women Phase 2/Phase 3
Recruiting NCT03416790 - IMPAACT 2015 - Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults With Cognitive Impairment
Recruiting NCT03570918 - MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy Phase 1
Not yet recruiting NCT03624413 - InTSHA: Interactive Transition Support for HIV-infected Adolescents Using Social Media N/A
Recruiting NCT03536234 - Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients Phase 2
Not yet recruiting NCT03549689 - Effect of Reducing Nucleotide Exposure on Bone Health (ReNew) Phase 2
Not yet recruiting NCT03705169 - Pharmacokinetics of SAR441236 Phase 1
Active, not recruiting NCT03251690 - Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression N/A
Recruiting NCT03532425 - B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults Phase 4
Not yet recruiting NCT03709355 - Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs Phase 1
Not yet recruiting NCT03580668 - Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide
Not yet recruiting NCT03199690 - A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers Phase 1
Active, not recruiting NCT01466582 - Comorbidity and Aging With HIV N/A
Recruiting NCT03148964 - Primary Infection Cohort N/A
Recruiting NCT03512210 - Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection Phase 4
Recruiting NCT03706898 - Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs Phase 1
Active, not recruiting NCT03312244 - Pyridostigmine as Immunomodulator in People Living With HIV Phase 2
Not yet recruiting NCT03719664 - Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects Phase 2
Withdrawn NCT03074786 - Reversing the Epidemic in Africa With Choices in HIV Prevention (REACH) Phase 2
Recruiting NCT03539224 - Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept. Phase 2